203 related articles for article (PubMed ID: 8928802)
1. Opossum colonic mucosa contains uroguanylin and guanylin peptides.
Hamra FK; Krause WJ; Eber SL; Freeman RH; Smith CE; Currie MG; Forte LR
Am J Physiol; 1996 Apr; 270(4 Pt 1):G708-16. PubMed ID: 8928802
[TBL] [Abstract][Full Text] [Related]
2. Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.
Hamra FK; Eber SL; Chin DT; Currie MG; Forte LR
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2705-10. PubMed ID: 9122260
[TBL] [Abstract][Full Text] [Related]
3. Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.
Forte LR
Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
[TBL] [Abstract][Full Text] [Related]
4. Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases.
Hamra FK; Fan X; Krause WJ; Freeman RH; Chin DT; Smith CE; Currie MG; Forte LR
Endocrinology; 1996 Jan; 137(1):257-65. PubMed ID: 8536621
[TBL] [Abstract][Full Text] [Related]
5. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.
Hamra FK; Forte LR; Eber SL; Pidhorodeckyj NV; Krause WJ; Freeman RH; Chin DT; Tompkins JA; Fok KF; Smith CE
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10464-8. PubMed ID: 7902563
[TBL] [Abstract][Full Text] [Related]
6. Guanylin peptides: cyclic GMP signaling mechanisms.
Forte LR; Freeman RH; Krause WJ; London RM
Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
[TBL] [Abstract][Full Text] [Related]
7. Structure and activity of uroguanylin and guanylin from the intestine and urine of rats.
Fan X; Hamra FK; London RM; Eber SL; Krause WJ; Freeman RH; Smith CE; Currie MG; Forte LR
Am J Physiol; 1997 Nov; 273(5):E957-64. PubMed ID: 9374682
[TBL] [Abstract][Full Text] [Related]
8. Structure and activity of OK-GC: a kidney receptor guanylate cyclase activated by guanylin peptides.
London RM; Eber SL; Visweswariah SS; Krause WJ; Forte LR
Am J Physiol; 1999 Jun; 276(6):F882-91. PubMed ID: 10362777
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human uroguanylin: a member of the guanylin peptide family.
Kita T; Smith CE; Fok KF; Duffin KL; Moore WM; Karabatsos PJ; Kachur JF; Hamra FK; Pidhorodeckyj NV; Forte LR
Am J Physiol; 1994 Feb; 266(2 Pt 2):F342-8. PubMed ID: 8141334
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of uroguanylin and guanylin in vivo.
Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
[TBL] [Abstract][Full Text] [Related]
11. Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity.
Forte LR; Fan X; Hamra FK
Am J Kidney Dis; 1996 Aug; 28(2):296-304. PubMed ID: 8768930
[TBL] [Abstract][Full Text] [Related]
12. Lymphoguanylin: cloning and characterization of a unique member of the guanylin peptide family.
Forte LR; Eber SL; Fan X; London RM; Wang Y; Rowland LM; Chin DT; Freeman RH; Krause WJ
Endocrinology; 1999 Apr; 140(4):1800-6. PubMed ID: 10098518
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone.
Greenberg RN; Hill M; Crytzer J; Krause WJ; Eber SL; Hamra FK; Forte LR
J Investig Med; 1997 Jun; 45(5):276-82. PubMed ID: 9250001
[TBL] [Abstract][Full Text] [Related]
14. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney.
Santos-Neto MS; Carvalho AF; Monteiro HS; Forte LR; Fonteles MC
Regul Pept; 2006 Sep; 136(1-3):14-22. PubMed ID: 16814407
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Escherichia coli heat-stable enterotoxin/guanylin/uroguanylin receptors in the avian intestinal tract.
Krause WJ; Freeman RH; Eber SL; Hamra FK; Fok KF; Currie MG; Forte LR
Acta Anat (Basel); 1995; 153(3):210-9. PubMed ID: 8984830
[TBL] [Abstract][Full Text] [Related]
16. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
Forte LR
Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
[TBL] [Abstract][Full Text] [Related]
17. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
[TBL] [Abstract][Full Text] [Related]
18. Guanylin peptides: renal actions mediated by cyclic GMP.
Forte LR; London RM; Freeman RH; Krause WJ
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F180-91. PubMed ID: 10662722
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological activity and isomerism of guanylate cyclase C-activating peptides guanylin and uroguanylin.
Klodt J; Kuhn M; Marx UC; Martin S; Rösch P; Forssmann WG; Adermann K
J Pept Res; 1997 Sep; 50(3):222-30. PubMed ID: 9309586
[TBL] [Abstract][Full Text] [Related]
20. Signaling pathways for guanylin and uroguanylin in the digestive, renal, central nervous, reproductive, and lymphoid systems.
Fan X; Wang Y; London RM; Eber SL; Krause WJ; Freeman RH; Forte LR
Endocrinology; 1997 Nov; 138(11):4636-48. PubMed ID: 9348189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
